Pharmacology Tildrakizumab was approved in March 2018 for A Psoriasis B HIV C Rheumatoid ahritis D Hepatitis C 💡 Explanation Tildrakizumab was approved in March 2018 for ✓ Correct Answer: A. Psoriasis